Epinephrine Injection
Product Images NDC 51662-1223

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Epinephrine (NDC 51662-1223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Case Label (1000240 0115 1695 30 Epinephrine Auto Injector .15mg)

Label for EPINEPHRINE injection, USP auto-injector with a strength of 0.15 mg. The label indicates it is for allergic emergencies, suitable for patients weighing 33 to 66 lbs. The NDC is 0115-1695-30, and the labeler is Impax. Instructions include 'TWIST AND PULL.' Revision date 07/2016.*

FDA Label Image

0.3 mL Caselabel (1000250 0115 1694 30 Epinephrine Auto Injector .30mg)

Label for EPINEPHRINE injection, USP auto-injector with 0.3 mg strength. The label includes the NDC 0115-1694-30 and instructions "TWIST AND PULL." It indicates use for allergic emergencies in patients weighing over 66 lbs. The label also shows the labeler Impax and revision date 07/2016.*

FDA Label Image

Inst 1 (Instructions 1)

Illustration of a Epinephrine 0.15 mg auto-injector showing labeled parts including the carrying case, end caps, red tip, viewing window, and auto-injector body. The image highlights design features for administration and handling of the 0.15 mg subcutaneous injection device.*

FDA Label Image

Inst 2 (Instructions 2)

Illustration showing the components of an Epinephrine 0.3 mg subcutaneous auto-injector and its carrying case. Labeled parts include the yellow and black carrying case, the auto-injector with two blue pull end caps, a red tip marked 'needle end,' and a viewing window on the injector body displaying the dosage strength.*

FDA Label Image

Inst 3 (Instructions 3)

An instructional illustration showing a subcutaneous injection device with a white body and red tip, indicating to pull off both blue caps. Arrows and text guide the user to remove the blue caps from either end of the device, labeled as Figure A.*

FDA Label Image

Inst 4 (Instructions 4)

An instructional illustration showing a person injecting epinephrine by pushing the red tip hard into the thigh for 10 seconds. The image includes a hand holding the injection device against the thigh with accompanying text guiding the user to apply firm pressure for 10 seconds.*

FDA Label Image

Inst 5 (Instructions 5)

An instructional illustration labeled Figure C showing two hands demonstrating the removal of a red-capped syringe from a black cylindrical protective cap, with an arrow indicating the direction of removal. The image appears to be part of usage instructions for the Epinephrine injection, subcutaneous dosage form.*

FDA Label Image

Inst 6 (Instructions 6)

An instructional illustration labeled 'Figure D' showing two hands holding an epinephrine injection device or pen, with an arrow indicating the direction in which the device should be moved or positioned.*

FDA Label Image

Serialized Label (Serialized 51662 1222 1 Epinephrine 0.15)

Epinephrine injection auto-injector in black and orange plastic casing with a white label showing part of the product name, a barcode, and small text including distributor information by HF Acquisition Co, LLC. The device is designed for subcutaneous use and intended as a human prescription drug.*

FDA Label Image

0.3ml Serialized Label (Serialized 51662 1223 1 Epinephrine 0.30)

Epinephrine subcutaneous injection autoinjector with a yellow ribbed bottom and black top. It has white labels with barcode and manufacturing details, distributed by HF Acquisition Co LLC, DBA HealthFirst. The device is designed for single use as indicated by RX ONLY markings.*

FDA Label Image

Structure (Structure)

Chemical structure of epinephrine showing a benzene ring with hydroxyl groups and an attached side chain including an amine group. This diagram represents the active ingredient epinephrine in the injectable product by HF Acquisition Co LLC, DBA HealthFirst.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.